NEXENTIS TECHNOLOGIES INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 286 shares for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-03-31
- NEXENTIS TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2022-12-31 was -36.08K shares.
- NEXENTIS TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-12-31 was -555.43K shares.
- NEXENTIS TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-09-30 was 500.00K shares.
- NEXENTIS TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 286.00 shares.
- NEXENTIS TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 6.01K shares.
- NEXENTIS TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2020 was 92.57K shares, a 15.48% decline from fiscal 2019.
- NEXENTIS TECHNOLOGIES INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2019 was 109.53K shares, a 73.71% decline from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | 286.00 shares 10-K · filed 2026-03-31 | 10.00K shares 10-K · filed 2025-03-31 | |||
| 2022-12-31 | -36.08K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 6.01K shares 10-K · filed 2024-04-01 | 42.10K shares 10-K · filed 2023-03-27 | ||
| 2022-09-30 | 42.10K shares 10-Q · filed 2022-11-14 | ||||
| 2020-12-31 | -555.43K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -55.43K shares derived: sum of 2 quarters · filed 2022-03-31 | 92.57K shares 10-K · filed 2022-03-31 | ||
| 2020-09-30 | 500.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 648.00K shares 10-Q · filed 2020-11-12 | |||
| 2020-06-30 | 148.00K shares 10-Q · filed 2020-08-11 | ||||
| 2019-12-31 | 109.53K shares 10-K · filed 2021-03-29 | 766.67K shares 10-K · filed 2020-03-30 | |||
| 2018-12-31 | 416.67K shares 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |